Dr. Hood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1851 S Kelly Ave
Ste A
Edmond, OK 73013Phone+1 405-607-6699
Summary
- Dr. Michael Hood is an ophthalmologist in Edmond, OK. He received his medical degree from University of Oklahoma College of Medicine and has been in practice 6 years. He specializes in retinal disease and uveitis and is experienced in diabetic retinopathy, sickle-cell retinopathy, macular degeneration, macular edema, and retinal detachment.
Education & Training
- Charles Retina InstituteFellowship, Surgical Retina and Vitreous, 2015 - 2017
- University of TennesseeResidency, Ophthalmology, 2012 - 2015
- Riverside Regional Medical CenterInternship, Transitional Year, 2011 - 2012
- University of Oklahoma College of MedicineClass of 2011
Certifications & Licensure
- AR State Medical License 2016 - 2026
- AZ State Medical License 2021 - 2025
- OK State Medical License 2018 - 2025
- TN State Medical License 2015 - 2025
- CA State Medical License 2016 - 2024
- MS State Medical License 2015 - 2018
- VA State Medical License 2011 - 2012
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Member Phi Beta Kappa
- Member Alpha Omega Alpha
Publications & Presentations
PubMed
- 21 citationsTemporal Macular Atrophy as a Predictor of Neovascularization in Sickle Cell Retinopathy.Michael Hood, Rocio I. Diaz, Eric J. Sigler, Jorge I. Calzada
Ophthalmic Surgery, Lasers & Imaging Retina. 2016-01-01 - 7 citationsAbnormal cone ERGs in a family with congenital nystagmus and photophobia harboring a p.X423Lfs mutation in the PAX6 geneMichael Hood, Natalie C. Kerr, Nizar Smaoui, Alessandro Iannaccone
Documenta Ophthalmologica. Advances in Ophthalmology. 2015-01-03
Abstracts/Posters
- Localized Inner Macular Atrophy as a Predictor of Neovascularization in Sickle Cell Retinopathy.Hood MP, Sigler EJ, Calzada JI., 14th EURETINA Annual Congress, London, England, 9/2014
- Bevacizumab as Adjunctive Therapy to Panretinal Photocoagulation in Eyes with Proliferative Sickle Cell Retinopathy.Hood MP, Sigler EJ, Brennen P, Calzada JI, 32nd American Society of Retina Specialists (ASRS) Annual Meeting, San Diego, CA, 8/2014
- Retinal Angiomatous Proliferation with Chorioretinal Anastomosis in Childhood Coats DiseaseHood MP, Sigler EJ, Randolph JC, Bell AP, Calzada JI., The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Orlando, FL, 5/2014
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: